Population pharmacokinetics and pharmacogenetics of vitamin d in hiv-positive patients
- At: 2014 FIP Congress in PSWC, Melbourne (Australia)
- Type: Presentation
- By: GUIDI, Monia (Lausanne, Switzerland)
Population pharmacokinetic modeling has been recognized over the past two decades as an essential component for accurate description of dose-concentration-effect relationships, identification of influential covariates and quantification and explanation of variability in drug concentrations among individuals who represent the target population.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.